AlphaMark Advisors’s Sanofi SNY Stock Holding History

AlphaMark Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-200	Closed	-$10K	–	822
2024 Q1	$10K	Hold	200	–	–	﹤0.01%	539
2023 Q4	$10K	Hold	200	–	–	﹤0.01%	523
2023 Q3	$11K	Hold	200	–	–	﹤0.01%	505
2023 Q2	$11K	Hold	200	–	–	0.01%	400
2023 Q1	$11K	Hold	200	–	–	﹤0.01%	399
2022 Q4	$10K	Hold	200	–	–	0.01%	378
2022 Q3	$8K	Hold	200	–	–	﹤0.01%	450
2022 Q2	$10K	Hold	200	–	–	﹤0.01%	400
2022 Q1	$10K	Hold	200	–	–	﹤0.01%	404
2021 Q4	$10K	Buy	+200	New	+$9.89K	﹤0.01%	398
2020 Q3	–	Sell	-100	Closed	-$5K	–	561
2020 Q2	$5K	Buy	100 +52	+108%	+$2.53K	﹤0.01%	435
2020 Q1	$2K	Buy	+48	New	+$2.3K	﹤0.01%	475
2017 Q3	–	Sell	-250	Closed	-$12K	–	538
2017 Q2	$12K	Hold	250	–	–	0.01%	327
2017 Q1	$11K	Hold	250	–	–	0.01%	326
2016 Q4	$10K	Buy	+250	New	+$9.85K	0.01%	315

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AlphaMark Advisors's SNY Position: Q2 2024 in Review

AlphaMark Advisors sold out of Sanofi (SNY) in Q2 2024, closing a stake of 200 shares — an estimated $10K sold.

AlphaMark Advisors first reported a position in SNY in Q4 2016 and held it in 15 quarters. The position peaked at $12K in Q2 2017. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2024.

AlphaMark Advisors reported no remaining Sanofi position as of Q2 2024 after selling out during the quarter.
AlphaMark Advisors sold 200 Sanofi shares in Q2 2024, an estimated $10K.
AlphaMark Advisors first reported a position in Sanofi in Q4 2016 and held it in 15 quarters.
AlphaMark Advisors's Sanofi position peaked at $12K in Q2 2017.
730 funds tracked by Wall St. Rank held Sanofi as of Q2 2024.

Based on AlphaMark Advisors's 13F filing for Q2 2024, filed 17 Jul 2024.